ストックスクリーナーアプリを入手
0.449
8.72%
0.036
Hcw Biologics Inc (HCWB) 最新ニュース
HCW Biologics issues 2.55 million shares to Armistice Capital By Investing.com - Investing.com Nigeria
HCW Biologics issues 2.55 million shares to Armistice Capital - Investing.com India
HCW Biologics Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
HCW Biologics takes aim at CD8+ in deal with WY Biotech - The Pharma Letter
HCW Biologics announces pricing of $6.9M registered direct offering, concurrent private placement - MSN
U.S. shares mixed at close of trade; Dow Jones Industrial Average down 0.13% - MSN
HCW Biologics : Announces Pricing of $6.9 Million Registered Direct Offering and Concurrent Private Placement Priced Above Market Under NASDAQ Rules Form 8 K - Marketscreener.com
HCW Biologics Expands with New Financial Agreements - TipRanks
HCW Biologics prices $6.9M registered direct offering at $1.03 per share - Yahoo Finance
Why Symbotic Shares Are Trading Higher By Over 28%; Here Are 20 Stocks Moving Premarket - Benzinga
Spotlight on Undervalued Nasdaq Stocks: HCWB, CRDL, NIVF, SINT, APLMA Must-Watch This Week! - Marketscreener.com
HCWB stock touches 52-week high at $1.97 amid robust gains - Investing.com Australia
HCW Biologics Announces Pricing of $6.9 Million Registered Direct Offering and Concurrent Private Placement Priced Above Market Under NASDAQ Rules - Yahoo Finance
HCW Biologics Secures $6.9M Above-Market Offering with Warrant Coverage | HCWB Stock News - StockTitan
HCW Biologics Announces Pricing of $6.9 Million Registered Direct Offering and Concurrent Private Placement Priced Above Market Under NASDAQ Rules - Benzinga
HCW Biologics Announces Pricing of $6.9 Million Registered - GlobeNewswire
Aclaris Therapeutics (ACRS): Strategic Alliance with Biosion Ignites 53% Stock Surge - BP Journal
Sintx Technologies, Inc. (SINT): A Bold Move with Strategic Stock Repurchase Program Boosts Investor Confidence - BP Journal
HCW Biologics Inc. (HCWB): A Strategic Leap with Worldwide Licensing Agreement Sends Stock Up Over 310% - BP Journal
United States shares mixed at close of trade; Dow Jones Industrial Average down 0.13% - Investing.com India
U.S. stocks mixed at close of trade; Dow Jones Industrial Average down 0.13% - Investing.com
U.S. STOCKS Henry Schein Inc, Palantir Technologies, Uber Technologies - XM
Owning 44% shares,institutional owners seem interested in Jamieson Wellness Inc. (TSE:JWEL), - Yahoo Finance
HCW Biologics signs licensing deal with WY Biotech - Investing.com India
Trinity Investors Managing Partner Sanjay Chandra Named One of Dallas Most Influential Leaders on DCEO’s Dallas 500 List - Yahoo Finance
HCW Biologics Shares Surge on License Agreement - MarketWatch
Broward pharma developer inks $7 million deal with Chinese firm - The Business Journals
Enphase Energy Powers Up with US-Made IQ Batteries: Unlocking Bonus Tax Credits - AOL
California logistics company files for Chapter 11 - Yahoo Finance
Crude Oil Rises Sharply; US Homebuilder Sentiment Surges In November - Benzinga
Spirit Airlines Declares Bankruptcy After Failed Merger and Rising Costs - Yahoo Finance
Stock Market News: HCW Biologics increase by 521.18% while CareMax drops by 49.20% during mid day trading - Business Upturn
Ultra low-cost carrier Spirit Airlines files for bankruptcy - Yahoo Finance
U.S. STOCKS Tesla Inc, Palantir Technologies and Super Micro Computer Inc - XM
Nvidia Stock Drops on Report of Snag With Blackwell Chip Servers - Yahoo Finance
Why Is Penny Stock HCW Biologics Surging On Monday? - Yahoo Finance
Dow Falls 100 Points; Brady Posts Upbeat Results - Benzinga
Wall Street Analysts See a 31.3% Upside in Adma Biologics (ADMA): Can the Stock Really Move This High? - Yahoo Finance
Stock market today: CareMax(−41.19%), HCW Biologics(+209.06%) among the most volatile stocks in early trading - Business Upturn
HCW Biologics and WY Biotech Announce License Agreement for Immunotherapeutic Product Candidate - GlobeNewswire
This tiny U.S biotech has made a big deal in China - RagingBull
HCWBHCW Biologics Inc. Latest Stock News & Market Updates - StockTitan
HCW Biologics : Financial Obligation Form 8 K - Marketscreener.com
Kandi Technologies Reports Third Quarter 2024 Financial Results - The Manila Times
HCW Biologics jumps on license agreement for immunotherapeutic product candidate - Seeking Alpha
MedinCell And 2 Other Top Growth Stocks With Strong Insider Ownership - Yahoo Finance
HCW Biologics Inc. and Wy Biotech Announce License Agreement for Immunotherapeutic Product Candidate - Marketscreener.com
Here's What Analysts Are Forecasting For ESCO Technologies Inc. (NYSE:ESE) After Its Yearly Results - Yahoo Finance
dynaCERT Third Quarter 2024 Earnings: CA$0.008 loss per share (vs CA$0.004 loss in 3Q 2023) - Yahoo Finance
Armlogi Holding First Quarter 2025 Earnings: US$0.11 loss per share (vs US$0.069 profit in 1Q 2024) - Yahoo Finance
HCW Biologics Third Quarter 2024 Earnings: US$0.10 loss per share (vs US$0.14 loss in 3Q 2023) - Simply Wall St
There's Been No Shortage Of Growth Recently For Royal Caribbean Cruises' (NYSE:RCL) Returns On Capital - Yahoo Finance
Samko Timber Third Quarter 2024 Earnings: Rp16.00 loss per share (vs Rp105 loss in 3Q 2023) - Yahoo Finance
Applied Materials Shares Slide on Disappointing Sales Forecast - Yahoo Finance
Analysts Have Made A Financial Statement On FiscalNote Holdings, Inc.'s (NYSE:NOTE) Third-Quarter Report - Yahoo Finance
OptiNose, Inc. (NASDAQ:OPTN) Just Reported, And Analysts Assigned A US$3.50 Price Target - Yahoo Finance
GCM Grosvenor (NASDAQ:GCMG) Is Paying Out A Dividend Of $0.11 - Yahoo Finance
November 2024 US Exchange Standouts: Promising Penny Stocks - Yahoo Finance
HCW Biologics Inc. (HCWB) Quarterly 10-Q Report - Quartz
HCW Biologics Reports Third Quarter 2024 Financial Results and Business Highlights - The Manila Times
2.88%
2.65%
大文字化:
|
ボリューム (24 時間):